Abstract:Background: Lung cancer patients who received lobectomy are at high risk of developing postoperative pulmonary complications. Clinical factors have been investigated to predict high risk patients; however, additional predictors are needed to accurately and reliably evaluate risk. Evidence has shown a relationship between the JAK-STAT pathway with pulmonary inflammation and lung injuries. Methods: We conducted a two stage discovery-validation study to evaluate the associations between genetic variations in JAK-STAT signaling pathway and the risk of developing postoperative pulmonary complications following lobectomy. A total of 223 SNPs from 27 genes were genotyped and analyzed in 264 early stage non-small cell lung cancer (NSCLC) patients who received lobectomy. Twelve significant (P<0.05) SNPs were then validated in additional 264 NSCLC patients. Results: Four SNPs showed a consistent effect in both discovery and validation populations and had a pooled p value < 0.05. Among them, PIAS3:rs10910829 was significantly associated with increased risk of developing complications in both the discovery (OR=1.78, 95%CI=1.16-2.74, P=0.008) and validation (OR=1.52, 95%CI=1.03-2.25, P=0.036) populations. PIAS2:rs9304337 was associated with decreased risk in the discovery set (OR= 0.45, 95%CI=0.21-0.95, P=0.037) and reached borderline significance (OR=0.53, 95%CI=0.26-1.05, P=0.071) in the validation set. A dose-response effect of increasing risk of developing complications with increasing number of unfavorable genotypes each patient carried was identified in the discovery population. Those with the highest number of unfavorable genotypes had an 8.82-fold increase (95% CI= 2.58-30.18) in risk compared to those with the lowest number. This effect was replicated in the validation population (P<0.001). A significant improvement in discriminatory ability was observed with the addition of the four genetic loci identified in our study to the epidemiological/clinical-based receiver operating characteristic curve in predicting the risk of developing complications. The area under the curve (AUC) was increased 8% from 0.68 for the initial model to 0.76 with the genetic variables. Bootstrap resampling internally validated the significance of this AUC difference (ΔAUC=0.024-0.129) and this improvement was replicated in the validation dataset. Conclusions: We identified genetic variations in the JAK-STAT pathway associated with risk of developing postoperative pulmonary complications in NSCLC patients. These biomarkers could be translated into the clinic to assist in identifying surgical patients who are at higher risk of developing pulmonary complications. Citation Format: Xia Pu, Michelle A.T. Hildebrandt, Jae Y. Kim, Yuanqing Ye, Ara A. Vaporciyan, Arlene M. Correa, Stephen G. Swisher, Jack A. Roth, Xifeng Wu. Genetic variations in the JAK-STAT pathway are associated with postoperative pulmonary complications after lobectomy in lung cancer patients. [abstract]. In: Proceedings of the Eleventh Annual AACR International Conference on Frontiers in Cancer Prevention Research; 2012 Oct 16-19; Anaheim, CA. Philadelphia (PA): AACR; Cancer Prev Res 2012;5(11 Suppl):Abstract nr B91.

Variations in the Vascular Endothelial Growth Factor Pathway Predict Pulmonary Complications.

Genetic Variation in the TNF/TRAF2/ASK1/p38 Kinase Signaling Pathway As Markers for Postoperative Pulmonary Complications in Lung Cancer Patients

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Abstract B91: Genetic Variations in the JAK-STAT Pathway Are Associated with Postoperative Pulmonary Complications after Lobectomy in Lung Cancer Patients

The Long-Term Impact of Postoperative Pulmonary Complications after Video-Assisted Thoracic Surgery Lobectomy for Lung Cancer

Genetic Variation In The P38 Signaling Pathway As Markers For Postoperative Pulmonary Complications In Lung Cancer Patients

Genetic Predisposition to Acute Lung Injury in Cardiac Surgery ‘the VEGF Factor’: Review Article and Bibliometric Analysis

Abstract 4663: Genetic Variation in the P38 Signaling Pathway As Markers for Postoperative Pulmonary Complications in Lung Cancer Patients

Inflammatory Gene Polymorphisms Influence Risk of Postoperative Morbidity after Lung Resection

Genetic Variants in Cytokine Signaling Pathways and Clinical Outcomes in Early-Stage Lung Cancer Patients

A Single Nucleotide Polymorphism in the Vascular Endothelial Growth Factor Gene is Associated with Recurrence of Hepatocellular Carcinoma after Transplantation.

Functional Flt1 Genetic Variation is A Prognostic Factor for Recurrence in Stage I-Iii Non-Small-Cell Lung Cancer

Correlation of genetic polymorphism of vascular endothelial growth factor gene with susceptibility to lung cancer

Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic obstructive pulmonary disease and lung cancer development in Chinese population.

Genetic Polymorphism in a VEGF-Independent Angiogenesis Gene ANGPT1 and Overall Survival of Colorectal Cancer Patients after Surgical Resection

The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer

Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients

Predictors of Venous Thromboembolism after Lung Cancer Resection

Abstract 1728: Genetic Variations in Epidermal Growth Factor Receptor Pathway Predict Recurrence and Response to Chemotherapy in Early Stage Non-Small Cell Lung Cancer

Association of genetic polymorphisms in the VEGF gene with breast cancer survival